Thermogenesis Holdings Inc THMO:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 04/22/24 EDT
0.65quote price arrow down-0.0126 (-1.9016%)
Volume
11,568
52 week range
0.36 - 2.44
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.65
  • 52 Week High2.44
  • 52 Week High Date05/01/23
  • 52 Week Low0.36
  • 52 Week Low Date01/25/24

Key Stats

  • Market Cap5.169M
  • Shares Out7.95M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta2.40
  • YTD % Change8.15

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.65
  • 52 Week High2.44
  • 52 Week High Date05/01/23
  • 52 Week Low0.36
  • 52 Week Low Date01/25/24
  • Market Cap5.169M
  • Shares Out7.95M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta2.40
  • YTD % Change8.15

RATIOS/PROFITABILITY

  • EPS (TTM)-8.60
  • P/E (TTM)-0.08
  • Fwd P/E (NTM)16.25
  • EBITDA (TTM)-5.427M
  • ROE (TTM)-1,367.44%
  • Revenue (TTM)9.445M
  • Gross Margin (TTM)20.44%
  • Net Margin (TTM)-200.31%
  • Debt To Equity (MRQ)-459.27%

EVENTS

  • Earnings Date05/13/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Thermogenesis Holdings Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
ThermoGenesis Holdings, Inc. develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. It provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and the CAR-TXpress platform for large scale cell manufacturing services. Its products include Clinical Bio-Banking Applications, Point-of-Care Applications and Large-Scale Cell...
Xiaochun Xu Ph.D.
Chairman of the Board, President, Chief Executive Officer
Haihong Zhu
Chief Operating Officer
Jeffery Cauble CPA
Chief Financial Officer
Address
2711 Citrus Rd
Rancho Cordova, CA
95742-6228
United States